Cognos develops business intelligence (BI) software that helps companies better analyze databases and business applications. Its 23,000 customers include marquee names like Home Depot
Fiscal fourth-quarter revenues increased 12% to $284.5 million, while earnings per share spiked 55% to $0.67. Cognos's sales team scored 25 contracts of $1 million or more, helping to push software license sales up 11% to $130 million. These revenues should lead to higher maintenance and service fees over the next few years.
The quarter's only drag was Cognos' drop in gross margins from 82.8% to 81.7% over the past year, drained by weakness in the company's services business. To fix these flaws, Cognos is redeploying key employees, working to generate greater demand, and adding incentives for education and e-learning offerings.
Ironically, the Oracle-Hyperion deal might actually benefit Cognos. Hyperion customers are probably concerned that Oracle could rework Hyperion's product line to fit better with its own databases and business applications. That could mean higher costs for Hyperion customers, should they eventually need to migrate to Oracle's offerings, making Cognos's rival products seem more appealing.
The Oracle deal also validates BI's importance and establishes a valuation benchmark. Hyperion sold for 3.4 times sales, compared to the 3.1 times sales at which Cognos currently trades.
With ample momentum in license revenues, and growing opportunities to pick off more customers from Hyperion, Cognos' management may not be interested in selling out right now -- at least, not before it's gained a bit more upside in its shares from Mr. Market.
I think, therefore I offer further Foolishness:
Amazon is a Stock Advisor pick; Home Depot is an Inside Value selection; and Dow Chemical made the cut at Income Investor. Try any of our Foolish newsletters free for 30 days.
More from The Motley Fool
Your 3-Point Guide to Paying Off Debt
Want to shake that debt for good? Here's how.
Are You Paying More for Health Insurance Than You Should Be?
When it comes to picking healthcare coverage, too many of us opt for plans that don't make any financial sense.
These 3 Stocks Are Undeniably Cheap
After a sharp sell-off in recent years, these pipeline companies sell for shockingly low prices.